Subscribe to Newsletter

Other

Business & Profession Other

Ophthalmology Futures Forum 2014: The Interviews

Find out what makes the meeting unique from the innovators and the investors who are driving the future of ophthalmology forward.

Business & Profession Other

Aflibercept and the Evolution of CRVO Management

Tackling visual impairment early, effectively and flexibly

Business & Profession Other

Reading Scleral Signals

The way that babies process information from eye expressions adds another piece to the social and emotional development puzzle

Business & Profession Other

The Road to Hell Is Paved with Good Intentions

| Mark Hillen

Maurice Saatchi wants new legislation to free British doctors from fear of litigation in the pursuit of innovation. Others view it as a charlatan’s charter

Business & Profession Retina

Should Steroids Be Your First Port of Call in the Pseudophakic Eye?

| José Cunha-Vaz

Anti-VEGF agents are effective in treating DME – but not always indefinitely. Steroids work – but accelerate cataract development.

Business & Profession Other

The Ophthalmologist Innovation Awards 2014

Showcasing the greatest ophthalmic advances of the year

Business & Profession Retina

The Art Of Eyes

Popular culture has always viewed eyes as being things of beauty. But there’s more to the eye than the color of your irides.

Business & Profession Cornea / Ocular Surface

Acanthamoeba Ate my Eyeballs

| Roisin McGuigan

A student lost sight in one eye after failing to remove her disposable contact lenses for six months. So how did tabloid journalists turn it into such a popular news story?

Business & Profession Basic & Translational Research

The Curious Case of Sirtuins

| Roisin McGuigan

SIRT1 appears to be an anti-aging protein that protects against weight gain, diabetes, inflammation, and even optic neuritis… in mouse models. Is SIRT1 the key to eternal youth, or simply snake oil?

Business & Profession Other

Shortsighted Scholars

| Mark Hillen

Is the potential dystopia that is myopia a consequence of too much study?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: